Jade Biosciences (JBIO) Current Assets (2020 - 2026)

Jade Biosciences has reported Current Assets for 7 years, with the latest figure at $318.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 311.66% year-over-year to $318.5 million; the trailing twelve-month figure through Mar 2026 stood at $318.5 million (up 311.66% YoY), and the FY2025 full-year result was $348.8 million, up 400.78% from the prior year.
• Current Assets for Q1 2026 stood at $318.5 million, down from $348.8 million in the prior quarter.
• The five-year high for Current Assets was $348.8 million in Q4 2025, with the low at $69.7 million in Q4 2024.
• Historically, Current Assets has averaged $157.3 million across 5 years, with a median of $137.6 million in 2023.
• Annual changes were most pronounced in 2024 — Current Assets slumped 43.93% — and 2025, when it soared 400.78%.
• Jade Biosciences' Current Assets stood at $131.5 million in 2022, then retreated by 5.52% to $124.2 million in 2023, then tumbled by 43.93% to $69.7 million in 2024, then soared by 400.78% to $348.8 million in 2025, then dropped by 8.69% to $318.5 million in 2026.
• The last three Current Assets figures came in at $318.5 million (Q1 2026), $348.8 million (Q4 2025), and $201.4 million (Q3 2025), per Business Quant data.